AI Day1 LLC Ups Stake in Day One Biopharma to 14.9%
Ticker: DAWN · Form: SC 13D/A · Filed: Aug 5, 2024 · CIK: 1845337
Sentiment: neutral
Topics: schedule-13d, beneficial-ownership, amendment
Related Tickers: DAYO
TL;DR
AI Day1 LLC now owns 14.9% of Day One Biopharma after filing an amended Schedule 13D.
AI Summary
On August 5, 2024, AI Day1 LLC filed an amendment (Amendment No. 4) to its Schedule 13D concerning Day One Biopharmaceuticals, Inc. The filing indicates a change in beneficial ownership, with AI Day1 LLC now holding 11,111,111 shares of common stock, representing approximately 14.9% of the outstanding shares. This filing follows a previous amendment on July 29, 2024, and involves entities such as Access Industries Holdings LLC and Len Blavatnik.
Why It Matters
This filing signals a significant increase in ownership by AI Day1 LLC in Day One Biopharmaceuticals, potentially indicating a strategic interest or a move towards greater influence over the company's direction.
Risk Assessment
Risk Level: medium — Increased stake by a significant entity can lead to changes in company strategy or potential takeover bids, introducing uncertainty.
Key Numbers
- 14.9% — Beneficial Ownership (Percentage of Day One Biopharmaceuticals, Inc. common stock held by AI Day1 LLC as of August 5, 2024.)
- 11,111,111 — Shares Owned (Number of common shares of Day One Biopharmaceuticals, Inc. held by AI Day1 LLC.)
Key Players & Entities
- AI Day1 LLC (company) — Filing entity increasing beneficial ownership
- Day One Biopharmaceuticals, Inc. (company) — Subject company
- Access Industries Holdings LLC (company) — Group member
- Len Blavatnik (person) — Group member
- Alejandro Moreno (person) — Signatory
FAQ
What is the total number of shares AI Day1 LLC now beneficially owns in Day One Biopharmaceuticals, Inc.?
AI Day1 LLC beneficially owns 11,111,111 shares of common stock in Day One Biopharmaceuticals, Inc.
What percentage of Day One Biopharmaceuticals, Inc. does AI Day1 LLC's ownership represent?
AI Day1 LLC's ownership represents approximately 14.9% of the outstanding shares of Day One Biopharmaceuticals, Inc.
When was this amendment to the Schedule 13D filed?
This amendment (Amendment No. 4) to the Schedule 13D was filed on August 5, 2024.
Who are the named group members in this filing?
The named group members include Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik.
What is the CUSIP number for Day One Biopharmaceuticals, Inc. common stock?
The CUSIP number for Day One Biopharmaceuticals, Inc. common stock is 23954D109.
Filing Stats: 2,680 words · 11 min read · ~9 pages · Grade level 15.7 · Accepted 2024-08-05 17:05:27
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
- $14.50 — of Common Stock at a purchase price of $14.50 per share and (ii) pre-funded warrants
- $14.4999 — of Common Stock at a purchase price of $14.4999 per Warrant. Each Warrant has an exerci
- $11,999,914.24 — f Common Stock at an aggregate price of $11,999,914.24. AI Day1 funded this purchase using cap
Filing Documents
- d881380dsc13da.htm (SC 13D/A) — 87KB
- d881380dex9912.htm (EX-99.12) — 9KB
- 0001193125-24-194017.txt ( ) — 98KB
From the Filing
SC 13D/A 1 d881380dsc13da.htm SC 13D/A SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Day One Biopharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 23954D109 (CUSIP Number) Alejandro Moreno Langhorne S. Perrow c/o Access Industries, Inc. 40 West 57 th Street, 28th Floor New York, New York 10019 (212) 247-6400 with copies to: Nicholas P. Pellicani Debevoise & Plimpton LLP 65 Gresham Street EC2V 7NQ London +44 20 7786 9000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 1, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. CUSIP No. 23954D109 1 NAME OF REPORTING PERSON. AI Day1 LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 12,929,322 shares 8 SHARED VOTING POWER 0 shares 9 SOLE DISPOSITIVE POWER 12,929,322 shares 10 SHARED DISPOSITIVE POWER 0 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,929,322 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 13.15% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) All percentages of ownership of Common Stock by the Reporting Persons presented in this Statement are based on the sum of (i) 87,760,456 shares of Common Stock issued and outstanding as of July 31, 2024, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission (the SEC) on August 2, 2024 and (ii) 10,551,718 shares of Common Stock issued on August 1, 2024 in the Private Placement (as defined below). CUSIP No. 23954D109 1 NAME OF REPORTING PERSON. Access Industries Holdings LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 12,929,322 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 12,929,322 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,929,322 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 13.15% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) All percentages of ownership of Common Stock by the Reporting Persons presented in this Statement are based on the sum of (i) 87,760,456 shares of Common Stock issued and outstanding as of July 31, 2024, as reported in the Issuers Form 10-Q filed with the SEC on August 2, 2024 and (ii) 10,551,718 shares of Common Stock issued on August 1, 2024 in the Private Placement. CUSIP No. 23954D109 1 NAME OF REPORTING PERSON. Access Industries Management, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 12,929,322 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 12,929,322 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,929,322 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 13.15% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) All percentages of ownership of Common Stock by the Reporting Persons presented in this Statement are based on the sum of (i) 87,760,456 shares of Common Stock issued and outstanding as of July 31, 2024, as reported in the Issuers Form 10-Q filed with the SEC on August 2, 2024 and (ii) 10,551,718 sha